Session Information
Title: Fibromyalgia, Soft Tissue Disorders, Regional and Specific Clinical Pain Syndromes: Research Focus
Session Type: Abstract Submissions (ACR)
Background/Purpose: Fibromyalgia patients are known to have poor sleep, but no distinct sleep signature has been identified. We use a simple device called Jawbone to evaluate sleep in patients with fibromyalgia and controls.
Methods: Patients meeting the 2010 ACR criteria for the diagnosis of fibromyalgia were given the Jawbone device to wear on their wrist to monitor sleep. Controls also wore the same device. Patients’ sleep was evaluated from the standpoint of number of awakenings, total duration of sleep, how deep was the sleep, and other factors.
Results: The total number of awakening of 12 of the fibromyalgia patients was 2.68, with the mean age being 46.5yrs, while the controls awakened an average of 1.2 times per night, with a mean age of 40.7.
The average period awake for the fibromyalgia group was 59 minutes, compared to 45.6 minutes for controls. Other totals were total sleep average 7.4 hours Fibromyalgia, 6.5 hours Controls. Sound sleep average, 4.0 hours Fibromyalgia, 3.2 hours Controls. Light Sleep average 3.4 hours fibromyalgia, 3.3 hours Controls. Total hours in bed, 8.4 hours fibromyalgia, 7.3 hours Controls. Time to fall asleep 17.7 minutes fibromyalgia, 27.7 minutes Controls. Out of the 12, most of the fibromyalgia patients were on a sleep aid, Elavil (7 patients), Doxepin (3 patients). The sleep study was preformed over one evening.
Conclusion: Fibromyalgia patients are known to sleep poorly. In this study we found that they awaken more often than controls and appear to be awake for longer periods of time. The reasons for this are unclear, but if there is a sleep pattern associated with fibromyalgia, it may simply be based on the number of awakenings in those without another clear factor, such as obstructive sleep apnea.
Using a sleep monitoring device, such as the Jawbone UP in this study, may be a simple method for patients and clinicians to monitor sleep, including the number of awakenings and the duration of non-sleeping time in FMS patients. One approach would be to evaluate patients’ sleep before and after tricyclic treatment.
Disclosure:
R. S. Katz,
None;
J. L. Polyak,
None.
« Back to 2014 ACR/ARHP Annual Meeting
ACR Meeting Abstracts - https://acrabstracts.org/abstract/do-fibromyalgia-patients-have-a-distinct-sleep-signature/